4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-25-000955
Options or other derivatives
- CEO acquired 496,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Vaddi Krishna CEO | 2025-02-04 | Grant or award · Employee Stock Option (right to buy) | +496,000 | 496,000 | D | ||
Loading xslF345X05/primarydocument.xml…